Fig. 1
From: STK25 enhances hepatocellular carcinoma progression through the STRN/AMPK/ACC1 pathway
High expression of STK25 protein in HCC patients. (a) STK25 expression in different tissues (Adjacent vs Tumor). (b) STK25 expression in human HCC tissues from TCGA (Normal vs Tumor). (c, d) Representative staining (200 ×) and quantification of STK25 expression in liver of control and HCC patients, the thick black arrow indicated STK25. (e) STK25 expression of 29 patients in our center. (f, g) Representative western blot and quantification of STK25 in liver of control and HCC patients. (h) STK25 expression from integrative molecular database of hepatocellular carcinoma (As Table 1). CON, control. Data are expressed as mean ± SD. *, p < 0.05. **, p < 0.01. ***, p < 0.001. Scale bars, 50 μm